- Tytuł:
-
Extended ICI treatment after first‐line chemoimmunotherapy could predict the clinical benefit of ramucirumab plus docetaxel in advanced non‐small
lung cancer : Post hoc analysis from NEJ051 (REACTIVE study). - Autorzy:
- Temat:
-
THERAPEUTIC use of antineoplastic agents
LUNG cancer
RESEARCH
DRUG efficacy
STATISTICS
IMMUNE checkpoint inhibitors
INTRAVENOUS therapy
CANCER chemotherapy
MULTIVARIATE analysis
RETROSPECTIVE studies
ANTINEOPLASTIC agents
FISHER exact test
DOCETAXEL
MEDICAL records
DESCRIPTIVE statistics
RESEARCH funding
PROGRESSION-free survival
DATA analysis
DATA analysis software
IMMUNOTHERAPY
OVERALL survival - Źródło:
- Thoracic Cancer; Jan2024, Vol. 15 Issue 2, p163-171, 9p
Czasopismo naukowe